Top compounds associated with response to MOGS


Feature Type Standardized
Nominal ANOVA
mRNA Doxorubicin gCSI pan-cancer AAC -0.12 0.02
mRNA ML210 CTRPv2 pan-cancer AAC -0.074 0.02
mRNA vorinostat:navitoclax (4:1 mol/mol) CTRPv2 pan-cancer AAC -0.079 0.02
mRNA decitabine CTRPv2 pan-cancer AAC -0.061 0.02
mRNA crizotinib:PLX-4032 (2:1 mol/mol) CTRPv2 pan-cancer AAC -0.076 0.03
mRNA Bleomycin GDSC1000 pan-cancer AAC 0.078 0.03
mRNA CIL56 CTRPv2 pan-cancer AAC -0.099 0.03
mRNA Ki8751 CTRPv2 pan-cancer AAC -0.078 0.03
mRNA oligomycin a CTRPv2 pan-cancer AAC -0.077 0.03
mRNA AKT inhibitor VIII GDSC1000 pan-cancer AAC 0.074 0.03
Download CSV